iohexol has been researched along with piperidines in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Carlsson, PO; Hansell, P; Liss, P; Nygren, A; Palm, F | 1 |
Cannon, C; Chan, G; Gruben, D; Krishnaswami, S; Lawendy, N; Swan, S; Wang, R | 1 |
Gong, Z; Gu, D; Han, Y; He, D; Ren, H; Shi, Y; Xia, T; Yang, J; Zeng, C | 1 |
1 trial(s) available for iohexol and piperidines
Article | Year |
---|---|
Effect of CP-690,550, an orally active janus kinase inhibitor, on renal function in healthy adult volunteers.
Topics: Administration, Oral; Adult; Double-Blind Method; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Iohexol; Janus Kinase 3; Kidney; Kidney Function Tests; Male; Middle Aged; p-Aminohippuric Acid; Piperidines; Placebos; Pyrimidines; Pyrroles; Renal Plasma Flow, Effective | 2009 |
2 other study(ies) available for iohexol and piperidines
Article | Year |
---|---|
Et-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia.
Topics: Animals; Antihypertensive Agents; Contrast Media; Disease Models, Animal; Endothelin Receptor Antagonists; Hypoxia; Iohexol; Kidney Diseases; Kidney Medulla; Male; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renal Circulation | 2003 |
AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Urea Nitrogen; Cell Adhesion Molecules; Cell Line; Contrast Media; Creatinine; Disease Models, Animal; Inflammation; Iohexol; Kidney Diseases; Lactate Dehydrogenases; Male; Oxidative Stress; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction | 2020 |